Polypharmacotherapy - More drugs, less health?;Polypharmakotherapie - Mehr medikamente, weniger gesundheit?

Zeitschrift fur Allgemeinmedizin

Volumn 87, Issue 3, 2011, Pages 108-110

  Sönnichsen, Andreas ^a  

^a Institut fur Allgemein   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; MEDICATION THERAPY MANAGEMENT; POLYPHARMACOTHERAPY;

EID: 80555134629     PISSN: 09376801     EISSN: 14399229     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Habl C, Bachner F. Das österreichische Gesundheitswesen im internationalen Vergleich. Wien: Österreichisches Bundesinstitut für Gesundheitswesen, 2010
2. Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007; 41: 1411-1426 (Pubitemid 47311361)
3. Schuler J, Duckelmann C, Beindl W, Prinz E, Michalski T, Pichler M. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 2008; 120: 733-741
4. Onder G, Pedone C, Landi F, Cesari M, Della VC, Bernabei R et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-1968 (Pubitemid 35462441)
5. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19 (Pubitemid 38869995)
6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205 (Pubitemid 28193431)
7. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54 (Pubitemid 34534816)
8. Rathore SS, Mehta SS, Boyko WL, Jr., Schulman KA. Prescription medication use in older Americans: a national report card on prescribing. Fam Med 1998; 30: 733-739 (Pubitemid 28525381)
9. Gundl S, Koper D, Sönnichsen A. Potentielle schwere Interaktionen bei Patienten mit Polypharmazie - Ergebnisse einer Pilotstudie: Unterschiedliche Klassifizierung von Interaktionen in verschiedenen Datenbanken. German Medical Science 2010; DOI: 10.3205/10ebm008, URN: urn:nbn:de:0183-10ebm0086
10. Koper D, Tache S, Sönnichsen A. Medikation ohne Evidenzbasis (EB) bei Patienten mit Polypharmazie - Ergebnisse einer Pilotstudie. German Medical Science 2010; DOI: 10.3205/10ebm112, URN: urn:nbn:de:0183-10ebm1127
11. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165: 68-74 (Pubitemid 40096084)
12. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005; 31: 4-11
13. Mangin D, Sweeney K, Heath I. Preventive health care in elderly people needs rethinking. BMJ 2007; 335: 285-287 (Pubitemid 47280803)
14. Tinetti ME, Bogardus ST, Jr., Agostini JV. Potential pitfalls of disease-specific-guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870-2874
15. Maeda K. Systematic review of the effects of improvement of prescription to reduce the number of medications in the elderly with polypharmacy. Yakugaku Zasshi 2009; 129: 631-645
16. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817-832 (Pubitemid 37159599)
17. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430-434 (Pubitemid 46979143)
18. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010; 170: 1648-1654
19. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-1536 (Pubitemid 27305197)
20. Beers MH, Ouslander JG, Fingold SF, Morgenstern H, Reuben DB, Rogers W et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684-689
21. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724 (Pubitemid 37517412)
22. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004; 79: 122-139 (Pubitemid 38018592)
23. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107: 543-551
24. Planton J, Edlund BJ. Strategies for reducing polypharmacy in older adults. J Gerontol Nurs 2010; 36: 8-12
25. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-679